Genus Pharmaceuticals has recently became the wholly owned UK subsidiary of STADA Arzneimittel AG, a German company with a large portfolio of existing generic drugs, as well as an impressive number in its pipeline. More
Within large pharmaceutical companies, the marketing and supply chain of long-established products may no longer be optimally managed. This provides a niche for companies that are able to identify the winners in these 'tail end' products. More
Labtec specializes in the development of transdermal drug delivery technologies that can give new life to ethical drugs approaching the end of their patent protection. More